000 | 01990 a2200577 4500 | ||
---|---|---|---|
005 | 20250518054858.0 | ||
264 | 0 | _c20191101 | |
008 | 201911s 0 0 eng d | ||
022 | _a1178-2013 | ||
024 | 7 |
_a10.2147/IJN.S212260 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Yixuan | |
245 | 0 | 0 |
_aIntegrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects. _h[electronic resource] |
260 |
_bInternational journal of nanomedicine _c2019 |
||
300 |
_a5849-5863 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCamphor _xchemistry |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDermatitis, Atopic _xchemically induced |
650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
650 | 0 | 4 |
_aEar _xpathology |
650 | 0 | 4 |
_aEmulsions _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin E _xblood |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMenthol _xchemistry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aOils _xchemistry |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 |
_aSkin Absorption _xdrug effects |
650 | 0 | 4 |
_aSpleen _xdrug effects |
650 | 0 | 4 |
_aSubstance P _xmetabolism |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWater Loss, Insensible _xdrug effects |
700 | 1 | _aCao, Sisi | |
700 | 1 | _aYu, Kaiyue | |
700 | 1 | _aYang, Fengdie | |
700 | 1 | _aYu, Xiuming | |
700 | 1 | _aZhai, Yuanhao | |
700 | 1 | _aWu, Chuanbin | |
700 | 1 | _aXu, Yuehong | |
773 | 0 |
_tInternational journal of nanomedicine _gvol. 14 _gp. 5849-5863 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S212260 _zAvailable from publisher's website |
999 |
_c30032325 _d30032325 |